Polydex Pharmaceuticals Limited (OTCMKTS:POLXF – Get Free Report) passed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $1.99 and traded as low as $1.99. Polydex Pharmaceuticals shares last traded at $1.99, with a volume of 2,000 shares traded.
Polydex Pharmaceuticals Stock Performance
The company has a market cap of $6.81 million and a P/E ratio of -8.27. The firm has a 50 day moving average price of $1.99 and a 200-day moving average price of $1.99.
Polydex Pharmaceuticals Company Profile
Polydex Pharmaceuticals Ltd. is a development stage company, which engages in manufacturing of bulk pharmaceutical intermediates for the worldwide veterinary pharmaceutical industry, and the development, manufacturing, and marketing of biotechnology-based products for the human pharmaceutical market.
Further Reading
- Five stocks we like better than Polydex Pharmaceuticals
- Learn Technical Analysis Skills to Master the Stock Market
- Comprehensive PepsiCo Stock Analysis
- 3 Stocks to Consider Buying in October
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- Most active stocks: Dollar volume vs share volume
- Bear Market Funds to Watch This Year
Receive News & Ratings for Polydex Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polydex Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
